BFRG and BFRGW Related Headlines
Go Back- BullFrog AI regains NASDAQ compliance with equity requirement
- BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement
- BullFrog AI Announces Participation at AACR Annual Meeting
- BullFrog AI secures deal with top 5 pharma company, raises capital
- BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
- BullFrog AI launches bfARENAS decision engine for drug portfolio strategy
- BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine
- BullFrog AI publishes white paper on data harmonization
- BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences
- BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025
- Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on October 30
- Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development
- Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on July 23
BFRG and BFRGW Related Press Releases
Go Back- BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement
- BullFrog AI Announces Participation at AACR Annual Meeting
- BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
- BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine
- BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences
- BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025
- Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on October 30
- Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development
- Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on July 23

